Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Halozyme
HALO
$11.2B
| $7.77M | ﹤0.01% |
289,716
-90,572
| -24% | -$2.04M |
|
|
CMA
2377
CALL
DELISTED
Comerica
CMA
| $7.75M | ﹤0.01% |
203,300
-28,600
| -12% | -$997K |
|
2378
PUT
Goodyear
GT
$1.76B
| $7.75M | ﹤0.01% |
866,000
-43,100
| -5% | -$327K |
|
2379
CALL
Tencent Music
TME
$14.5B
| $7.75M | ﹤0.01% |
575,500
+305,500
| +113% | +$3.62M |
|
2380
PUT
Scorpio Tankers
STNG
$3.98B
| $7.74M | ﹤0.01% |
604,500
+317,900
| +111% | +$5.76M |
|
|
CNST
2381
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $7.74M | ﹤0.01% |
257,414
+167,767
| +187% | +$6.04M |
|
2382
Globant
GLOB
$1.61B
| $7.73M | ﹤0.01% |
51,594
+44,544
| +632% | +$5.5M |
|
|
MPT
2383
Medical Properties Trust
MPT
$2.5B
| $7.72M | ﹤0.01% |
+410,876
| New | +$7.28M |
|
|
RNAM
2384
DELISTED
Avidity Biosciences
RNAM
| $7.72M | ﹤0.01% |
+273,220
| New | +$7.88M |
|
2385
PUT
JetBlue
JBLU
$2.13B
| $7.72M | ﹤0.01% |
708,000
+297,000
| +72% | +$2.93M |
|
2386
PUT
Cooper Companies
COO
$14.9B
| $7.71M | ﹤0.01% |
108,800
+28,800
| +36% | +$2.13M |
|
2387
CALL
DXC Technology
DXC
$1.72B
| $7.71M | ﹤0.01% |
467,500
+214,700
| +85% | +$3.41M |
|
2388
CALL
Charles River Laboratories
CRL
$13.4B
| $7.71M | ﹤0.01% |
44,200
+22,800
| +107% | +$3.64M |
|
2389
Universal Health Services
UHS
$10B
| $7.7M | ﹤0.01% |
82,879
-27,382
| -25% | -$2.74M |
|
2390
American Homes 4 Rent
AMH
$12.3B
| $7.7M | ﹤0.01% |
286,118
+46,112
| +19% | +$1.15M |
|
2391
Cognex
CGNX
$11B
| $7.68M | ﹤0.01% |
128,659
-143,048
| -53% | -$7.77M |
|
2392
Sturm, Ruger & Co
RGR
$602M
| $7.68M | ﹤0.01% |
101,061
+67,838
| +204% | +$4.12M |
|
2393
CALL
Plug Power
PLUG
$3.24B
| $7.66M | ﹤0.01% |
933,100
+2,300
| +0.2% | +$10.8K |
|
2394
PUT
StoneCo
STNE
$2.32B
| $7.65M | ﹤0.01% |
197,400
+51,100
| +35% | +$1.49M |
|
2395
Grocery Outlet
GO
$1.1B
| $7.65M | ﹤0.01% |
187,455
+88,480
| +89% | +$3.17M |
|
2396
PUT
Repligen
RGEN
$9.42B
| $7.64M | ﹤0.01% |
61,800
+41,900
| +211% | +$4.93M |
|
2397
CALL
Lear
LEA
$8.32B
| $7.63M | ﹤0.01% |
70,000
+22,000
| +46% | +$2.19M |
|
|
NVO
2398
CALL
Novo Nordisk
NVO
$201B
| $7.62M | ﹤0.01% |
232,800
+82,000
| +54% | +$2.62M |
|
2399
B&G Foods
BGS
$294M
| $7.61M | ﹤0.01% |
312,252
+235,531
| +307% | +$5.1M |
|
2400
iShares International Select Dividend ETF
IDV
$8.59B
| $7.61M | ﹤0.01% |
303,022
+48,498
| +19% | +$1.17M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.